The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS

The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS

Bibliographic Details
Main Authors: Talbot, T, Dangoor, A, Shah, R, Naik, J, Talbot, D, Lester, J, Cipelli, R, Patel, A, Summerhayes, M, Newsom-Davis, T
Format: Journal article
Published: Elsevier 2017

Similar Items